FDA Approval: Blinatumomab
Przepiorka, Donna, Ko, Chia-Wen, Deisseroth, Albert, Yancey, Carolyn L, Candau-Chacon, Reyes, Chiu, Haw-Jyh, Gehrke, Brenda J, Gomez-Broughton, Candace, Kane, Robert C, Kirshner, Susan, Mehrotra, Nitin, Ricks, Tiffany K, Schmiel, Deborah, Song, Pengfei, Zhao, Ping, Zhou, Qing, Farrell, Ann T, Pazdur, Richard
Published in Clinical cancer research (15.09.2015)
Published in Clinical cancer research (15.09.2015)
Get full text
Journal Article
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
Wahby, Sakar, Fashoyin-Aje, Lola, Osgood, Christy L, Cheng, Joyce, Fiero, Mallorie H, Zhang, Lijun, Tang, Shenghui, Hamed, Salaheldin S, Song, Pengfei, Charlab, Rosane, Dorff, Sarah E, Ricks, Tiffany K, Barnett-Ringgold, Kimberly, Dinin, Jeannette, Goldberg, Kirsten B, Theoret, Marc R, Pazdur, Richard, Amiri-Kordestani, Laleh, Beaver, Julia A
Published in Clinical cancer research (01.04.2021)
Published in Clinical cancer research (01.04.2021)
Get full text
Journal Article
Immunoglobulin E plays an immunoregulatory role in lupus
Dema, Barbara, Charles, Nicolas, Pellefigues, Christophe, Ricks, Tiffany K, Suzuki, Ryo, Jiang, Chao, Scheffel, Jorg, Hasni, Sarfaraz, Hoffman, Victoria, Jablonski, Mathieu, Sacré, Karim, Gobert, Delphine, Papo, Thomas, Daugas, Eric, Crampton, Steve, Bolland, Silvia, Rivera, Juan
Published in The Journal of experimental medicine (20.10.2014)
Published in The Journal of experimental medicine (20.10.2014)
Get full text
Journal Article
Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis
Dema, Barbara, Pellefigues, Christophe, Hasni, Sarfaraz, Gault, Nathalie, Jiang, Chao, Ricks, Tiffany K, Bonelli, Michael M, Scheffel, Jörg, Sacré, Karim, Jablonski, Mathieu, Gobert, Delphine, Papo, Thomas, Daugas, Eric, Illei, Gabor, Charles, Nicolas, Rivera, Juan
Published in PloS one (28.02.2014)
Published in PloS one (28.02.2014)
Get full text
Journal Article
Successes and Challenges of PARP Inhibitors in Cancer Therapy
Ricks, Tiffany K, Chiu, Haw-Jyh, Ison, Gwynn, Kim, Geoffrey, McKee, Amy E, Kluetz, Paul, Pazdur, Richard
Published in Frontiers in oncology (14.10.2015)
Published in Frontiers in oncology (14.10.2015)
Get full text
Journal Article
Protease-activated receptor-2 is essential for factor viia and Xa-induced signaling, migration, and invasion of breast cancer cells
MORRIS, Dionne R, YU DING, RICKS, Tiffany K, GULLAPALLI, Anuradha, WOLFE, Breann L, TREJO, Joann
Published in Cancer research (Chicago, Ill.) (2006)
Published in Cancer research (Chicago, Ill.) (2006)
Get full text
Journal Article
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Kim, Geoffrey, Ison, Gwynn, McKee, Amy E, Zhang, Hui, Tang, Shenghui, Gwise, Thomas, Sridhara, Rajeshwari, Lee, Eunice, Tzou, Abraham, Philip, Reena, Chiu, Haw-Jyh, Ricks, Tiffany K, Palmby, Todd, Russell, Anne Marie, Ladouceur, Gaetan, Pfuma, Elimika, Li, Hongshan, Zhao, Liang, Liu, Qi, Venugopal, Rajesh, Ibrahim, Amna, Pazdur, Richard
Published in Clinical cancer research (01.10.2015)
Published in Clinical cancer research (01.10.2015)
Get full text
Journal Article
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Chang, Elaine, Weinstock, Chana, Zhang, Lijun, Charlab, Rosane, Dorff, Sarah E, Gong, Yutao, Hsu, Vicky, Li, Fang, Ricks, Tiffany K, Song, Pengfei, Tang, Shenghui, Waldron, Peter E, Yu, Jingyu, Zahalka, Eias, Goldberg, Kirsten B, Pazdur, Richard, Theoret, Marc R, Ibrahim, Amna, Beaver, Julia A
Published in Clinical cancer research (15.02.2021)
Published in Clinical cancer research (15.02.2021)
Get full text
Journal Article
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Fallah, Jaleh, Agrawal, Sundeep, Gittleman, Haley, Fiero, Mallorie H, Subramaniam, Sriram, John, Christy, Chen, Wei, Ricks, Tiffany K, Niu, Gang, Fotenos, Anthony, Wang, Min, Chiang, Kelly, Pierce, William F, Suzman, Daniel L, Tang, Shenghui, Pazdur, Richard, Amiri-Kordestani, Laleh, Ibrahim, Amna, Kluetz, Paul G
Published in Clinical cancer research (01.05.2023)
Published in Clinical cancer research (01.05.2023)
Get full text
Journal Article
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
Narayan, Preeti, Osgood, Christy L, Singh, Harpreet, Chiu, Haw-Jyh, Ricks, Tiffany K, Chiu Yuen Chow, Edwin, Qiu, Junshan, Song, Pengfei, Yu, Jingyu, Namuswe, Frances, Guiterrez-Lugo, Maria, Hou, Sherry, Pierce, William F, Goldberg, Kirsten B, Tang, Shenghui, Amiri-Kordestani, Laleh, Theoret, Marc R, Pazdur, Richard, Beaver, Julia A
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Narayan, Preeti, Prowell, Tatiana M, Gao, Jennifer J, Fernandes, Laura L, Li, Emily, Jiang, Xiling, Qiu, Junshan, Fan, Jianghong, Song, Pengfei, Yu, Jingyu, Zhang, Xinyuan, King-Kallimanis, Bellinda L, Chen, Wei, Ricks, Tiffany K, Gong, Yutao, Wang, Xing, Windsor, Katherine, Rhieu, Steve Y, Geiser, Gerlie, Banerjee, Anamitro, Chen, Xiaohong, Reyes Turcu, Francisca, Chatterjee, Deb K, Pathak, Anand, Seidman, Jeffrey, Ghosh, Soma, Philip, Reena, Goldberg, Kirsten B, Kluetz, Paul G, Tang, Shenghui, Amiri-Kordestani, Laleh, Theoret, Marc R, Pazdur, Richard, Beaver, Julia A
Published in Clinical cancer research (01.04.2021)
Published in Clinical cancer research (01.04.2021)
Get full text
Journal Article
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors
Fallah, Jaleh, Brave, Michael H, Weinstock, Chana, Mehta, Gautam U, Bradford, Diana, Gittleman, Haley, Bloomquist, Erik W, Charlab, Rosane, Hamed, Salaheldin S, Miller, Claudia P, Dorff, Sarah E, Chambers, Wiley A, Mixter, Bronwyn D, Dinin, Jeannette, Pierce, William F, Ricks, Tiffany K, Tang, Shenghui, Donoghue, Martha, Pazdur, Richard, Amiri-Kordestani, Laleh, Ibrahim, Amna, Beaver, Julia A
Published in Clinical cancer research (14.11.2022)
Published in Clinical cancer research (14.11.2022)
Get full text
Journal Article
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma
Chang, Elaine, Weinstock, Chana, Zhang, Lijun, Fiero, Mallorie H, Zhao, Miao, Zahalka, Eias, Ricks, Tiffany K, Fourie Zirkelbach, Jeanne, Qiu, Junshan, Yu, Jingyu, Chen, Xiao Hong, Bhatnagar, Vishal, Goldberg, Kirsten B, Tang, Shenghui, Kluetz, Paul G, Pazdur, Richard, Ibrahim, Amna, Beaver, Julia A, Amiri-Kordestani, Laleh
Published in Clinical cancer research (01.02.2022)
Published in Clinical cancer research (01.02.2022)
Get full text
Journal Article
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Dilawari, Asma, Shah, Mirat, Ison, Gwynn, Gittleman, Haley, Fiero, Mallorie H, Shah, Ankit, Hamed, Salaheldin S, Qiu, Junshan, Yu, Jingyu, Manheng, Wimolnut, Ricks, Tiffany K, Pragani, Rajan, Arudchandran, Arulvathani, Patel, Paresma, Zaman, Shadia, Roy, Arpita, Kalavar, Shyam, Ghosh, Soma, Pierce, William F, Rahman, Nam Atiqur, Tang, Shenghui, Mixter, Bronwyn D, Kluetz, Paul G, Pazdur, Richard, Amiri-Kordestani, Laleh
Published in Clinical cancer research (02.10.2023)
Published in Clinical cancer research (02.10.2023)
Get full text
Journal Article
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
Saber, Haleh, Del Valle, Pedro, Ricks, Tiffany K., Leighton, John K.
Published in Regulatory toxicology and pharmacology (01.11.2017)
Published in Regulatory toxicology and pharmacology (01.11.2017)
Get full text
Journal Article
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer
Shah, Mirat, Lingam, Hima, Gao, Xin, Gittleman, Haley, Fiero, Mallorie H, Krol, Danielle, Biel, Nikolett, Ricks, Tiffany K, Fu, Wentao, Hamed, Salaheldin, Li, Fang, Sun, Jillian Jielin, Fan, Jianghong, Schuck, Robert, Grimstein, Manuela, Tang, Liuya, Kalavar, Shyam, Abukhdeir, Abdelrahmman, Pathak, Anand, Ghosh, Soma, Bulatao, Ilynn, Tilley, Amy, Pierce, William F, Mixter, Bronwyn D, Tang, Shenghui, Pazdur, Richard, Kluetz, Paul, Amiri-Kordestani, Laleh
Published in Journal of clinical oncology (01.04.2024)
Published in Journal of clinical oncology (01.04.2024)
Get full text
Journal Article
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Heiss, Brian L, Chang, Elaine, Gao, Xin, Truong, Tien, Brave, Michael H, Bloomquist, Erik, Shah, Ankit, Hamed, Salaheldin, Kraft, Jeffrey, Chiu, Haw-Jyh, Ricks, Tiffany K, Tilley, Amy, Pierce, William F, Tang, Liuya, Abukhdeir, Abdelrahmman, Kalavar, Shyam, Philip, Reena, Tang, Shenghui, Pazdur, Richard, Amiri-Kordestani, Laleh, Kluetz, Paul G, Suzman, Daniel L
Published in Journal of clinical oncology (20.05.2024)
Published in Journal of clinical oncology (20.05.2024)
Get full text
Journal Article
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer
Royce, Melanie, Osgood, Christy L, Amatya, Anup K, Fiero, Mallorie H, Chang, C J George, Ricks, Tiffany K, Shetty, Krithika A, Kraft, Jeffrey, Qiu, Junshan, Song, Pengfei, Charlab, Rosane, Yu, Jingyu, King, Kathryn E, Rastogi, Anshu, Janelsins, Brian, Weinberg, Wendy C, Clouse, Kathleen, Borders-Hemphill, Vicky, Brown, Lindsey, Gomez-Broughton, Candace, Li, Zhong, Nguyen, Thuy Thanh, Qiu, Zhihao, Ly, Anh-Thy, Chang, Suyoung, Gao, Tingting, Tu, Chi-Ming, King-Kallimanis, Bellinda, Pierce, William F, Chiang, Kelly, Lee, Clara, Goldberg, Kirsten B, Leighton, John K, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh
Published in Clinical cancer research (14.04.2022)
Published in Clinical cancer research (14.04.2022)
Get full text
Journal Article